Copyright
©The Author(s) 2017.
World J Cardiol. Feb 26, 2017; 9(2): 196-199
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.196
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.196
Figure 1 Transprosthetic gradients and effective orifice area following transcatheter aortic valve replacement (2 to 54 mo), at the time transcatheter heart valve thrombosis (54 mo) and following anticoagulation therapy (54 to 63 mo).
TAVR: Transcatheter aortic valve replacement; THV: Transcatheter heart valve.
- Citation: Couture EL, Lepage S, Masson JB, Daneault B. Very late transcatheter heart valve thrombosis. World J Cardiol 2017; 9(2): 196-199
- URL: https://www.wjgnet.com/1949-8462/full/v9/i2/196.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i2.196